l General Information |
Product Name | Bufexamac |
General description | Bufexamac is a COX inhibitor for IFN-α release with EC50 of 8.9 μM. |
Synonym | 2-(4-butoxyphenyl)-N-hydroxyacetamide |
Purity | ≥98.0%(HPLC) | CAS Number | 2438-72-4 |
Formula | C12H17NO3 | Molecular Weight | 223.272 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White to off-white Wolid |
Solubility(25°C) | DMSO | ≥35mg/mL |
Ethanol | Slightly soluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol
Actions | Bufexamac is a hydroxamic acid derived from phenylacetamide in which the benzene moiety is substituted at C-4 by a butoxy group. It has anti-inflammatory, analgesic, and antipyretic properties. It has a role as a non-narcotic analgesic, a non-steroidal anti-inflammatory drug and an antipyretic. It is a hydroxamic acid and an aromatic ether. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
